欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4955/001
药品名称Amiodaron Hameln 20 mg/ml solution for infusion
活性成分
    • amiodarone hydrochloride 20.0 mg/ml
剂型Solution for infusion
上市许可持有人Hameln Pharma GmbH Langes Feld 13 Hameln 31789 Germany
参考成员国 - 产品名称Netherlands (NL)
Amiodaron HCl Hameln 20 mg/ml, oplossing voor infusie
互认成员国 - 产品名称
    • Germany (DE)
      Amiodaron-hameln 20 mg/ml Infusionlösung
    • Austria (AT)
      Amiodaron-hameln 20 mg/ml lnfusionslösung
    • Italy (IT)
    • Hungary (HU)
    • Czechia (CZ)
      Amiodaron Hameln
    • Slovenia (SI)
      Amjodaron hameln 20 mg/ml raztopina za infundiranje
    • Croatia (HR)
      Amiodaronklorid Hameln 20 mg/ml otopina za infuziju
    • United Kingdom (Northern Ireland) (XI)
许可日期2020/11/12
最近更新日期2022/07/21
药物ATC编码
    • C01BD01 amiodarone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase